Concomitant acral necrosis and haemolytic uraemic syndrome following ingestion of quinine

Journal of Postgraduate Medicine

Volumn 48, Issue 3, 2002, Pages 197-198

  Agarwal, N ^a   Cherascu, B ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Acral necrosis; Corticosteroids; Haemolytic uraemic syndrome; Quinine

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; HEPARIN; PREDNISONE; QUININE SULFATE;

ACRAL NECROSIS; AGED; ARTERY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FINGER; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; ISCHEMIA; MALE; MICROVASCULATURE; NECROSIS; PLASMAPHERESIS; RAYNAUD PHENOMENON; SKIN BIOPSY; THROMBOCYTE AGGLUTINATION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TOE; VASCULAR DISEASE;

ADRENAL CORTEX HORMONES; AGED; BIOPSY, NEEDLE; FOLLOW-UP STUDIES; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NECROSIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; QUININE; RISK ASSESSMENT; TOES; TREATMENT OUTCOME;

EID: 0036662834     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rock GA. Management of thrombotic thrombocytopenic purpura. Br J Haematol 2000;109:496-507.
2. Kojouri K, Vesely SK, George JN. Quinine associated thrombotic thrombocytopenic purpura- hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med 2001;135: 1047-51.
3. Freemont AJ, Hoyland J, Fielding P, Hodson N, Jayson MI. Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalised microangiopathy. Br J Dermatol 1992;126:561-8.
4. Knock GA, Terenghi G, Bunker CB, Bull HA, Dowd PM, Polak JM. Characterization of endothelin-binding sites in human skin and their regulation in primary Raynaud's phenomenon and systemic sclerosis. J Invest Dermatol 1993;101:73-8.
5. Abreu-Gerke L, Goerz G, Miller A, Ruzicka T. Acral necroses after therapy with quinine sulfate for calf cramps. Hautarzt 2000;51:332-5.
6. Gottschall JL, Elliot W, Lianos E, McFarland JG, Wolfmeyer K, Aster RH. Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity. Blood 1991;77:306-10.
7. Gottschall JL, Neahring B, McFarland JG, Wu GG, Weitekamp LA, Aster RH. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literature. Am J Hematol 1994;47:283-9.
8. Stroncek DF, Vercellotti GM, Hammerschmidt DE, Christie DJ, Shankar RA, Jacob HS. Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis. Blood 1992;80:241-8.
9. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
10. Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-94.
11. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991;325:398-403.
12. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991; 325:393-7.